Understanding MCAS – Symptoms, Cause
What is MCAS?
Mast cell activation syndrome, or MCAS for short, is a condition in which certain immune cells—called mast cells—overreact. Mast cells are part of the immune system and play an important role in defense responses, for example, in allergies or inflammation. In MCAS, these cells release increased amounts of messenger substances such as histamine, tryptase, and other inflammatory mediators. This can lead to a wide variety of symptoms, often affecting multiple organ systems.
What are typical symptoms of MCAS?
Typical symptoms can include: skin reactions such as redness, itching, or flushing; gastrointestinal issues such as abdominal pain, diarrhea, or nausea; circulatory problems, palpitations, or dizziness; headaches, fatigue, or difficulty concentrating. The symptoms can occur in episodes and be exacerbated by various triggers, such as certain foods, stress, temperature changes, or infections.
What does MCAS have to do with ME/CFS and Long Covid?
Mast cell activation syndrome (MCAS) and ME/CFS, also known as Long Covid, are distinct illnesses, but some individuals may experience them together. Both affect multiple bodily systems and are frequently associated with alterations in the immune system, the nervous system, and bodily regulation. Mast cells release messenger substances such as histamine and other inflammatory mediators. When these cells become overactive, it can lead to symptoms such as circulatory problems, gastrointestinal symptoms, skin reactions, or severe fatigue. Some of these symptoms can overlap with those also seen in ME/CFS. Researchers are therefore discussing whether mast cell activation might play a role in the complex disease process in some individuals. However, the precise connection is still under investigation.
What are possible biological connections?
MCAS is now understood as a multisystem disorder. Research is investigating, among other things, changes in: the regulation of the nervous system, the function of the immune system, energy production in cells, and communication between different body systems. These complex interrelationships are the subject of current scientific research.
How is MCAS diagnosed?
Diagnosing mast cell activation syndrome (MCAS) can be challenging because the symptoms can vary widely and affect multiple organ systems. Currently, there is no single test that definitively diagnoses MCAS. Therefore, physicians typically rely on three key components: First, typical symptoms consistent with mast cell activation, such as skin reactions (flushing, itching), gastrointestinal issues, circulatory problems, palpitations, or shortness of breath. Second, laboratory tests that measure specific mast cell signaling molecules, such as tryptase, histamine, or breakdown products like methylhistamine in the urine. These values can indicate mast cell activation but are not always conclusive. Third, the response to treatment, for example, medications that block the effects of histamine or other mast cell signaling molecules. Additionally, further tests are often conducted to rule out other conditions that can cause similar symptoms.
Is it possible to recover from MCAS?
The course of mast cell activation syndrome (MCAS) can vary considerably. In some people, symptoms persist for extended periods, while in others, symptoms can improve significantly or even subside in phases. Since MCAS can have various triggers and influencing factors, treatment usually focuses on identifying triggers, reducing symptoms, and stabilizing the mast cell response. Uniform cure rates are not currently available. However, many affected individuals report that their symptoms improve significantly over time with appropriate treatment.
Is MCAS an autoimmune disease?
Mast cell activation syndrome (MCAS) is not classified as a classic autoimmune disease. In autoimmune diseases, the immune system specifically targets and attacks the body's own structures. In MAS, the problem lies in the overactivation of mast cells, which are specific immune cells. These cells release increased amounts of messenger substances such as histamine and other inflammatory mediators, which can lead to various symptoms. In some cases, autoantibodies have been found in affected individuals that may affect mast cells or certain receptors. Therefore, researchers are investigating whether autoimmune-like mechanisms might be involved in some patients. However, a definitive classification as a classic autoimmune disease has not yet been established.